EMA Focuses On Rapidly Evolving Myasthenia Gravis Drug Development Field

 
• By Neena Brizmohun
  
Concept of Myasthenia Gravis written on sticky notes isolated on Wooden Table.
The EMA is working on developing guidance for drug developers targeting myasthenia gravis • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from Pink Sheet